RTW Investments’s Maravai LifeSciences MRVI Stock Holding History

RTW Investments’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,532,685	Closed	-$19.1M	–	71
2023 Q2	$19.1M	Buy	+1,532,685	New	+$20.7M	0.36%	39
2021 Q3	–	Sell	-70,000	Closed	-$2.92M	–	123
2021 Q2	$2.92M	Hold	70,000	–	–	0.04%	99
2021 Q1	$2.5M	Hold	70,000	–	–	0.04%	100
2020 Q4	$1.96M	Buy	+70,000	New	+$1.95M	0.03%	93

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

RTW Investments's MRVI Position: Q3 2023 in Review

RTW Investments sold out of Maravai LifeSciences (MRVI) in Q3 2023, closing a stake of 1,532,685 shares — an estimated $19.1M sold.

RTW Investments first reported a position in MRVI in Q4 2020 and held it in 4 quarters. The position peaked at $19.1M in Q2 2023. 204 funds tracked by Wall St. Rank hold MRVI as of Q3 2023.

RTW Investments reported no remaining Maravai LifeSciences position as of Q3 2023 after selling out during the quarter.
RTW Investments sold 1,532,685 Maravai LifeSciences shares in Q3 2023, an estimated $19.1M.
RTW Investments first reported a position in Maravai LifeSciences in Q4 2020 and held it in 4 quarters.
RTW Investments's Maravai LifeSciences position peaked at $19.1M in Q2 2023.
204 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2023.

Based on RTW Investments's 13F filing for Q3 2023, filed 14 Nov 2023.